dual agonist tirzepatide Decoding tirzepatide's agonism with advanced pharmacology assays hormone GLP Tirzepatide 10mg — GLP-1/GIP Dual-Agonist

Common side effects such as nausea, vomiting, and diarrhea often occur during the initial phase of treatment and typically improve as the body adjusts to the medication

However, some common side effects of Tirzepatide can lead to headaches

It does not provide an individualized diagnosis, medication recommendation, or treatment plan

Starting tirzepatide at a low dose and titrating gradually reduces nausea while allowing your body to adjust

Tirzepatide is a groundbreaking medication that has shown promise in helping individuals achieve significant weight loss, particularly for those dealing with obesity or metabolic conditions such as high blood pressure, type 2 diabetes, or high cholesterol